GSK3B and lung cancer: These observations are in line with our findings that GSK3β plays a key role in the activation of the DNA DSB repair pathway in FHIT-deficient lung cancer cells and that the GSK3β inhibitor sensitizes FHIT-deficient cells to genotoxic stress.